Busulfan

Overview

Busulfan is a chemotherapy drug that acts as an alkylating agent, primarily used in bone marrow transplantation conditioning regimens. It helps destroy bone marrow and malignant cells in chronic myelogenous leukemia treatment.

API suppliers (8)

Suppliers of Busulfan evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• FARMABIOS SPAItaly1 active DMF
• Emcure Pharmaceuticals LimitedIndia1 active DMF GMP on record
• SHILPA PHARMA LIFESCIENCES LTDIndia1 active DMF
• ARTHUR GROUP LLCAustralia1 active DMF
• APICORE US LLCUnited States1 active DMF
• EXCELLA GMBH AND CO KGGermany
• EUTICALS SPAItaly
• FRESENIUS KABI ONCOLOGY LTDIndia GMP on record

EU CEP holders (6)

Companies holding a valid EU Certificate of Suitability (CEP) for Busulfan, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.

Therapeutic areas